OrthoPediatrics (KIDS) stock price, revenue, and financials
OrthoPediatrics market cap is $1.1 b, and annual revenue was $37.30 m in FY 2016
$55.8
$1.1 B
KIDS Mkt cap, 26-Feb-2021$12.4 M
OrthoPediatrics Revenue Q3, 2017OrthoPediatrics Gross profit (Q3, 2017)9.5 M
OrthoPediatrics Gross profit margin (Q3, 2017), %76.7%
OrthoPediatrics Net income (Q3, 2017)-1.5 M
OrthoPediatrics EBIT (Q3, 2017)-756 K
OrthoPediatrics Cash, 30-Sept-20172.2 M
OrthoPediatrics EV1.1 B
OrthoPediatrics Revenue
OrthoPediatrics revenue was $37.30 m in FY, 2016 which is a 20.3% year over year increase from the previous period.
OrthoPediatrics Income Statement
Annual
| USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Revenue | 23.7m | 31.0m | 37.3m |
Revenue growth, % | 31% | 20% | |
Cost of goods sold | 7.1m | 9.4m | 10.9m |
Gross profit | 16.6m | 21.6m | 26.4m |
Gross profit Margin, % | 70% | 70% | 71% |
Sales and marketing expense | 12.2m | 15.0m | 16.7m |
R&D expense | 1.7m | 1.8m | 2.2m |
General and administrative expense | 9.9m | 11.4m | 11.6m |
Operating expense total | 23.7m | 28.2m | 30.5m |
EBIT | (7.1m) | (6.6m) | (6.1m) |
EBIT margin, % | (30%) | (21%) | (16%) |
Interest expense | 2.5m | 1.2m | 1.5m |
Net Income | (9.5m) | (7.9m) | (6.6m) |
Quarterly
| USD | Q3, 2016 | Q3, 2017 |
|---|---|---|
Revenue | 10.1m | 12.4m |
Cost of goods sold | 3.0m | 2.9m |
Gross profit | 7.2m | 9.5m |
Gross profit Margin, % | 71% | 77% |
Sales and marketing expense | 4.3m | 5.6m |
R&D expense | 501.0k | 1.1m |
General and administrative expense | 2.9m | 3.5m |
Operating expense total | 7.7m | 10.2m |
EBIT | (523.0k) | (756.0k) |
EBIT margin, % | (5%) | (6%) |
Interest expense | 399.0k | 761.0k |
Net Income | (845.0k) | (1.5m) |
OrthoPediatrics Balance Sheet
Annual
| USD | FY, 2015 | FY, 2016 |
|---|---|---|
Cash | 3.9m | 1.6m |
Accounts Receivable | 3.8m | 4.1m |
Prepaid Expenses | 222.0k | 233.0k |
Inventories | 11.7m | 14.0m |
Current Assets | 22.5m | 20.8m |
PP&E | 7.3m | 8.6m |
Total Assets | 30.7m | 30.7m |
Accounts Payable | 2.0m | 3.5m |
Short-term debt | 101.0k | 107.0k |
Current Liabilities | 6.3m | 7.3m |
Long-term debt | 13.0m | 17.4m |
Non-Current Liabilities | 13.0m | 17.4m |
Total Debt | 13.1m | 17.5m |
Total Liabilities | 19.4m | 24.7m |
Common Stock | 1.0k | 1.0k |
Additional Paid-in Capital | 17.4m | 12.8m |
Retained Earnings | (71.6m) | (78.1m) |
Total Equity | (54.1m) | (65.3m) |
Debt to Equity Ratio | -0.2 x | -0.3 x |
Debt to Assets Ratio | 0.4 x | 0.6 x |
Financial Leverage | -0.6 x | -0.5 x |
Quarterly
| USD | Q2, 2017 | Q3, 2017 |
|---|---|---|
Cash | 2.3m | 2.2m |
Accounts Receivable | 6.5m | 5.7m |
Prepaid Expenses | 960.0k | 615.0k |
Inventories | 18.1m | 19.0m |
Current Assets | 28.8m | 28.9m |
PP&E | 9.8m | 9.7m |
Total Assets | 40.0m | 41.1m |
Accounts Payable | 6.1m | 5.1m |
Short-term debt | 110.0k | 111.0k |
Current Liabilities | 10.4m | 10.4m |
Long-term debt | 25.4m | 27.5m |
Non-Current Liabilities | 25.4m | 27.5m |
Total Debt | 25.5m | 27.6m |
Total Liabilities | 35.8m | 37.9m |
Common Stock | 1.0k | 1.0k |
Additional Paid-in Capital | 10.7m | 9.5m |
Retained Earnings | (80.7m) | (82.2m) |
Total Equity | (69.9m) | (72.5m) |
Debt to Equity Ratio | -0.4 x | -0.4 x |
Debt to Assets Ratio | 0.6 x | 0.7 x |
Financial Leverage | -0.6 x | -0.6 x |
OrthoPediatrics Cash Flow
Annual
| USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Net Income | (9.5m) | (7.9m) | (6.6m) |
Depreciation and Amortization | 1.6m | 1.9m | 1.9m |
Accounts Receivable | 375.0k | (1.0m) | (280.0k) |
Inventories | (360.0k) | 1.6m | (1.0m) |
Accounts Payable | (445.0k) | 1.4m | 1.5m |
Cash From Operating Activities | (9.9m) | (892.0k) | (1.1m) |
Purchases of PP&E | (3.1m) | (2.2m) | (4.3m) |
Cash From Investing Activities | (3.3m) | (1.7m) | (4.8m) |
Cash From Financing Activities | 19.7m | (98.0k) | 3.6m |
Net Change in Cash | 6.5m | (2.7m) | (2.3m) |
Interest Paid | 2.5m | 1.2m | 1.5m |
Quarterly
| USD | Q2, 2016 | Q3, 2016 | Q2, 2017 | Q3, 2017 |
|---|---|---|---|---|
Net Income | (2.1m) | (2.9m) | (2.6m) | (4.1m) |
Depreciation and Amortization | 903.0k | 1.4m | 1.1m | 1.7m |
Accounts Receivable | (695.0k) | (74.0k) | (2.4m) | (1.6m) |
Inventories | (2.8m) | (3.6m) | ||
Accounts Payable | 1.9m | 1.8m | 2.6m | 1.6m |
Cash From Operating Activities | (2.3m) | (2.4m) | (4.2m) | (3.9m) |
Purchases of PP&E | (1.8m) | (2.6m) | (2.8m) | (3.9m) |
Cash From Investing Activities | (1.8m) | (3.0m) | (3.1m) | (5.3m) |
Cash From Financing Activities | 1.4m | 2.9m | 8.0m | 9.8m |
Net Change in Cash | (2.7m) | (2.6m) | 697.0k | 629.0k |
Interest Paid | 657.0k | 1.1m | 1.1m | 1.9m |
OrthoPediatrics Ratios
| USD | FY, 2014 |
|---|
